Rebekah J. Harms
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Rebekah J. Harms has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Rachel A. Ankeny
4 shared publicationsAditi Mankad
Advanced Engineering Biology Future Science Platform, CSIRO, Brisbane, QLD, Australia
2 shared publications- Aditi Mankad
CSIRO Environment, CSIRO Advanced Engineering Biology Future Science Platform, Brisbane, Australia
2 shared publications Jackie Leach Scully
Disability Innovation Institute, UNSW Sydney, Sydney, NSW, Australia
2 shared publications- Jackie Leach Scully
Jackie Leach Scully is professor of Bioethics and director of the Disability Innovation Institute at the University of New South Wales, Sydney, Australia
2 shared publications Lucy Carter
Advanced Engineering Biology Future Science Platform, CSIRO, Brisbane, QLD, Australia
2 shared publications
Latest Publications
- Open Access
- 27 April 2026
- Published by Springer Nature in AI and Ethics
- Vol. 6 (3) , 270
Problems with a one-size-fits-all approach: a systematic literature review on solutions to AI bias in healthcare and implications for engineering biology
- 27 April 2026
- Published by Springer Nature in AI and Ethics
- Vol. 6 (3) , 270
Open AccessProblems with a one-size-fits-all approach: a systematic literature review on solutions to AI bias in healthcare and implications for engineering biology
- Open Access
- 19 February 2026
- Published by Center for Open Science in SocArXiv
Narrating Science and the Public Good: Insights from Australian Stem Cell Research
Science policy actors increasingly invoke the public good in their visions for supporting and doing scientific research. But how do they and working scientists make sense of this relationship? And what do their perspectives mean for the normative question of how we ought to think about the interface of science and public good? While STS has much to contribute here, we have seen little sustained engagement with these questions in the field, a gap we seek to address. We revisit Michel Callon’s 1994 article ‘Is Science a Public Good?’, putting his contribution in conversation with more recent STS insights and empirical findings on narratives around stem cell research in Australia. Based on this analysis, we identify three narratives of science and public good: two that are prominent in contemporary discussions (essentialist, market-oriented) and another that speaks to possible alternatives (ambivalent). Seeking to expand upon the ambivalent narrative in order to point towards more normative possibilities, we argue that today the challenge is to transform how scientific research is configured in this world in order to allow diverse publics, priorities, and pathways to be built in pursuit of public good.
- 19 February 2026
- Published by Center for Open Science in SocArXiv
Open AccessNarrating Science and the Public Good: Insights from Australian Stem Cell Research
Science policy actors increasingly invoke the public good in their visions for supporting and doing scientific research. But how do they and working scientists make sense of this relationship? And what do their perspectives mean for the normative question of how we ought to think about the interface of science and public good? While STS has much to contribute here, we have seen little sustained engagement with these questions in the field, a gap we seek to address. We revisit Michel Callon’s 1994 article ‘Is Science a Public Good?’, putting his contribution in conversation with more recent STS insights and empirical findings on narratives around stem cell research in Australia. Based on this analysis, we identify three narratives of science and public good: two that are prominent in contemporary discussions (essentialist, market-oriented) and another that speaks to possible alternatives (ambivalent). Seeking to expand upon the ambivalent narrative in order to point towards more normative possibilities, we argue that today the challenge is to transform how scientific research is configured in this world in order to allow diverse publics, priorities, and pathways to be built in pursuit of public good.
- 12 February 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 26 (2) , 112-114
Developers Are Central for Mitigation of AI Bias
- 12 February 2026
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 26 (2) , 112-114
Developers Are Central for Mitigation of AI Bias
- Open Access
- 13 January 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1752729
Can AI developers avoid bias in public health applications?
Developments in the field of engineering biology and artificial intelligence have made it increasingly possible to deliver personalised treatments which are tailored to the individual and can help prevent illnesses before they occur. While such advancements have important implications for public health, the use of AI-enabled personalised treatments comes with potential downsides, not least of which is the potential for bias which may cause harm to certain subpopulations. As one of the key actors in the AI development pipeline, developers are ideally placed to ensure that treatments are designed in an equitable manner. However, existing bias mitigation strategies often fail to consider the practical challenges faced by developers which can significantly impact their abilities to detect and remove bias from any treatments which they help to design. In this paper, we highlight some of the practical challenges that developers face in mitigating bias. We also consider the implications of acknowledging such limitations for attributing responsibility related to bias mitigation.
- 13 January 2026
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 13, 1752729
Open AccessCan AI developers avoid bias in public health applications?
Developments in the field of engineering biology and artificial intelligence have made it increasingly possible to deliver personalised treatments which are tailored to the individual and can help prevent illnesses before they occur. While such advancements have important implications for public health, the use of AI-enabled personalised treatments comes with potential downsides, not least of which is the potential for bias which may cause harm to certain subpopulations. As one of the key actors in the AI development pipeline, developers are ideally placed to ensure that treatments are designed in an equitable manner. However, existing bias mitigation strategies often fail to consider the practical challenges faced by developers which can significantly impact their abilities to detect and remove bias from any treatments which they help to design. In this paper, we highlight some of the practical challenges that developers face in mitigating bias. We also consider the implications of acknowledging such limitations for attributing responsibility related to bias mitigation.
- Open Access
- 26 November 2025
- Published by Center for Open Science in SocArXiv
Problems With a One-Size-Fits-All Approach: A Systematic Literature Review on Solutions to AI Bias in Engineering Biology
Much of the current literature on artificial intelligence bias in healthcare presents a one-size-fits-all approach to bias mitigation. Such approaches, however, are unlikely to offer actionable guidance to those developers (and their institutions) who are looking for strategies to minimise potential bias. This paper presents findings from a systematic literature review exploring existing work on how AI developers can mitigate bias in the field of engineering biology. A systematic search was conducted on the Scopus and Web of Science databases for relevant articles published between 2015 and 2024. The findings from 51 reviewed articles showed that recommendations for bias mitigation within healthcare tended to be grouped around seven key themes, namely diversity in teams, training and education, awareness and responsibility, diversity of data, collaboration with end users and beneficiaries, monitoring and evaluation, and transparency. While these recommendations provide useful suggestions for reducing bias, they generally fail to provide actionable guidance or empirical evidence about how these strategies can be operationalised in a real-world setting. More research is needed to test the effectiveness and practicality of these recommendations across different scientific and clinical contexts as well as among different types of development teams.
- 26 November 2025
- Published by Center for Open Science in SocArXiv
Open AccessProblems With a One-Size-Fits-All Approach: A Systematic Literature Review on Solutions to AI Bias in Engineering Biology
Much of the current literature on artificial intelligence bias in healthcare presents a one-size-fits-all approach to bias mitigation. Such approaches, however, are unlikely to offer actionable guidance to those developers (and their institutions) who are looking for strategies to minimise potential bias. This paper presents findings from a systematic literature review exploring existing work on how AI developers can mitigate bias in the field of engineering biology. A systematic search was conducted on the Scopus and Web of Science databases for relevant articles published between 2015 and 2024. The findings from 51 reviewed articles showed that recommendations for bias mitigation within healthcare tended to be grouped around seven key themes, namely diversity in teams, training and education, awareness and responsibility, diversity of data, collaboration with end users and beneficiaries, monitoring and evaluation, and transparency. While these recommendations provide useful suggestions for reducing bias, they generally fail to provide actionable guidance or empirical evidence about how these strategies can be operationalised in a real-world setting. More research is needed to test the effectiveness and practicality of these recommendations across different scientific and clinical contexts as well as among different types of development teams.
- Open Access
- 1 January 2024
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 23
Emergent Design and Unanticipated Ideas in Asynchronous Online Focus Groups: Finding an Unexpected Silver Lining in Apparent Methodological Compromise
This article explores methodological advantages and limitations of using asynchronous online focus groups (AOFGs) as an approach to investigating community attitudes and values relating to biotechnology in food production. We describe our experiences using AOFGs during the COVID-19 pandemic as a form of emergent design. We highlight the methodological advantages and limitations of such research approaches, particularly to explore unanticipated ideas relating to community attitudes and values associated with biotechnology in food production. Although AOFGs are not a direct substitute for traditional methodologies, there are clear advantages that can outweigh typical concerns, depending on the research questions and goals, particularly when research aims to involve participants from diverse demographic groups and engage in more emergent methods allowing unanticipated ideas to be explored. As a result of having to pivot our methods to produce the required analyses during the COVID-19 pandemic, this paper provides valuable insights into the use of AOFGs to capture qualitative data when use of traditional methods is restricted or may be less desirable.
- 1 January 2024
- Published by SAGE Publications in International Journal of Qualitative Methods
- Vol. 23
Open AccessEmergent Design and Unanticipated Ideas in Asynchronous Online Focus Groups: Finding an Unexpected Silver Lining in Apparent Methodological Compromise
This article explores methodological advantages and limitations of using asynchronous online focus groups (AOFGs) as an approach to investigating community attitudes and values relating to biotechnology in food production. We describe our experiences using AOFGs during the COVID-19 pandemic as a form of emergent design. We highlight the methodological advantages and limitations of such research approaches, particularly to explore unanticipated ideas relating to community attitudes and values associated with biotechnology in food production. Although AOFGs are not a direct substitute for traditional methodologies, there are clear advantages that can outweigh typical concerns, depending on the research questions and goals, particularly when research aims to involve participants from diverse demographic groups and engage in more emergent methods allowing unanticipated ideas to be explored. As a result of having to pivot our methods to produce the required analyses during the COVID-19 pandemic, this paper provides valuable insights into the use of AOFGs to capture qualitative data when use of traditional methods is restricted or may be less desirable.